RxDoctor Payments DataLook up a doctor →

Amir Piracha, MD

Cardiovascular Disease · Louisville, KYNPI 1578555942

Payments from drug & device makers

$589,960in general payments, 2019–2025

Across 2,409 payments — averaging $244.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$176K
  • Penumbra, Inc.$132K
  • Johnson & Johnson$93K
  • Novartis$72K
  • Bayer$35K
  • Scpharmaceuticals Inc.$33K
  • plus $50K from 52 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca324$175,624
Penumbra, Inc.140$132,368
Johnson & Johnson322$92,830
Novartis253$71,504
Bayer65$34,604
Scpharmaceuticals Inc.89$33,429
Boston Scientific167$13,416
Abbott261$10,979
Merck50$6,129
Terumo Medical Corporation59$2,282
Medtronic(2 entities)39$1,986
Amgen134$1,962
E.r. Squibb & Sons, L.L.C.59$1,286
Cardiovascular Systems Inc.42$1,153
Chiesi USA, Inc.35$1,142
Esperion Therapeutics, Inc.83$1,006
Boehringer Ingelheim30$711
Johnson & Johnson Surgical Vision, Inc.1$600
EKOS Corporation11$519
Janssen Scientific Affairs, LLC6$515
Philips North America LLC15$508
Pfizer26$473
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)22$461
Celonova Biosciences, Inc.2$416
Sanofi-aventis U.S. LLC23$369
Kowa Pharmaceuticals America, Inc.27$297
Abiomed8$292
Vital Connect, Inc14$285
Novo Nordisk11$280
Actelion Pharmaceuticals US, Inc.9$256
Amarin Pharma, Inc.13$204
Kestra Medical Technology Services, Inc.2$201
Bridgebio Pharma, Inc.5$179
Cvrx, Inc.6$145
Lexicon Pharmaceuticals, Inc.7$134
AOP Health US, LLC1$128
La Jolla Pharmaceutical Company1$111
Inari Medical, Inc.3$104
Astellas Pharma US Inc2$102
Siemens Medical Solutions USA, Inc.5$101
Vero Biotech Inc.1$91
Tetraphase Pharmaceuticals, Inc.1$86
Kiniksa Pharmaceuticals International, PLC4$86
Teleflex LLC3$84
Angiodynamics, Inc.2$70
Heartflow, Inc.3$57
Acacia Pharma Inc6$50
ZOLL Circulation Inc2$50
Regeneron Healthcare Solutions, Inc.3$47
Vifor Pharma, Inc.2$45
Cook Medical LLC2$38
Biotronik Inc.2$35
Shockwave Medical, Inc1$30
Silk Road Medical, Inc.1$24
Thrombolex, Inc.1$21
Amryt Pharma Holdings Ltd1$20
Livanova USA, Inc.1$18
Baxter Healthcare1$17

How this compares

$589,960 in reported general payments places this provider in the 95th percentile of 258 cardiovascular disease providers in Kentucky.

See all cardiovascular disease providers in Kentucky →

Medicare billing

Part B allowed, 2024
$190,804
Medicare patients
1,076
Services billed
2,413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Louisville

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →